SEC Form 4 · accession 0001144204-16-124460

Altimmune, Inc. · ALT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President and CEO · Director

Period of report

Sep 15, 2016

Accepted (ET)

Sep 19, 2016 · 6:00 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001326190

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock, par value $0.0001 per share	Sep 15, 2016	M	20,000	$1.60	A	632,244	D
Common Stock, par value $0.0001 per share	Sep 15, 2016	M	20,000	$1.45	A	652,244	D
Common Stock, par value $0.0001 per share	Sep 15, 2016	M	20,000	$1.64	A	672,244	D
Common Stock, par value $0.0001 per share	Sep 15, 2016	M	20,000	$1.51	A	692,244	D
Common Stock, par value $0.0001 per share	Sep 16, 2016	M	10,000	$2.59	A	702,244	D
Common Stock, par value $0.0001 per share	Sep 16, 2016	M	20,000	$2.47	A	722,244	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Employee Stock Option (right to buy)	$1.60	Sep 15, 2016	M	20,000	D	Jun 23, 2010	Jun 23, 2020	Common Stock	20,000	D
Employee Stock Option (right to buy)	$1.45	Sep 15, 2016	M	20,000	D	Jun 22, 2013	Jun 22, 2022	Common Stock	20,000	D
Employee Stock Option (right to buy)	$1.64	Sep 15, 2016	M	20,000	D	Jun 11, 2014	Jun 11, 2023	Common Stock	20,000	D
Employee Stock Option (right to buy)	$1.51	Sep 15, 2016	M	20,000	D	Jun 18, 2015	Jun 17, 2024	Common Stock	20,000	D
Employee Stock Option (right to buy)	$2.59	Sep 16, 2016	M	10,000	D	Mar 9, 2009	Jun 13, 2018	Common Stock	10,000	D
Employee Stock Option (right to buy)	$2.47	Sep 16, 2016	M	20,000	D	Aug 5, 2009	Aug 5, 2019	Common Stock	20,000	D